IL51988A - Anti-tumor agents containing lysolecithin analogues - Google Patents

Anti-tumor agents containing lysolecithin analogues

Info

Publication number
IL51988A
IL51988A IL51988A IL5198877A IL51988A IL 51988 A IL51988 A IL 51988A IL 51988 A IL51988 A IL 51988A IL 5198877 A IL5198877 A IL 5198877A IL 51988 A IL51988 A IL 51988A
Authority
IL
Israel
Prior art keywords
analogues
agents containing
tumor agents
containing lysolecithin
lysolecithin
Prior art date
Application number
IL51988A
Other versions
IL51988A0 (en
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of IL51988A0 publication Critical patent/IL51988A0/en
Publication of IL51988A publication Critical patent/IL51988A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL51988A 1976-05-04 1977-05-02 Anti-tumor agents containing lysolecithin analogues IL51988A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2619686A DE2619686C2 (en) 1976-05-04 1976-05-04 Use of a lysolecithin for tumor treatment

Publications (2)

Publication Number Publication Date
IL51988A0 IL51988A0 (en) 1977-07-31
IL51988A true IL51988A (en) 1981-05-20

Family

ID=5977045

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51988A IL51988A (en) 1976-05-04 1977-05-02 Anti-tumor agents containing lysolecithin analogues

Country Status (15)

Country Link
JP (1) JPS52134027A (en)
AU (1) AU517586B2 (en)
BE (1) BE854270A (en)
CA (1) CA1094455A (en)
DE (1) DE2619686C2 (en)
FR (1) FR2364656A1 (en)
GB (1) GB1583661A (en)
IE (1) IE44927B1 (en)
IL (1) IL51988A (en)
IT (1) IT1071329B (en)
LU (1) LU77248A1 (en)
NL (1) NL189672C (en)
NZ (1) NZ183981A (en)
SE (1) SE7705071L (en)
ZA (1) ZA772649B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5396311A (en) * 1977-01-29 1978-08-23 Toyama Chem Co Ltd Anti-cander drugs containing lysolecithins
JPS5528955A (en) * 1978-08-24 1980-02-29 Toyama Chem Co Ltd Novel glycerophosphoric acid derivative, its salt, their preparation, and carcinostatic agent containing the same.
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
US4551532A (en) * 1980-05-08 1985-11-05 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
EP0050327B1 (en) * 1980-10-21 1984-06-20 Roche Diagnostics GmbH Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
EP0061872B1 (en) * 1981-03-30 1985-08-07 Takeda Chemical Industries, Ltd. Ethyleneglycol derivatives, their production and use
DE3127503A1 (en) * 1981-07-11 1983-02-17 Boehringer Mannheim Gmbh, 6800 Mannheim NEW PHOSPHOLIPIDS, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3131524A1 (en) * 1981-08-08 1983-02-24 Röhm GmbH, 6100 Darmstadt METHOD FOR PRODUCING PHYSIOLOGICAL EFFECTORS
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
DE3239817A1 (en) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen NEW GLYCER DERIVATIVES FOR THE SYNTHESIS OF PHOSPHOLIPIDES
DE3239858A1 (en) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen NEW D-MANNITE DERIVATIVES AS STARTING PRODUCTS FOR THE SYNTHESIS OF PHOSPHOLIPIDES
EP0103877B1 (en) * 1982-09-21 1987-01-07 Fujisawa Pharmaceutical Co., Ltd. Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same
US4710579A (en) * 1984-11-09 1987-12-01 Takeda Chemical Industries, Ltd. 2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
DE3662197D1 (en) 1985-07-15 1989-04-06 Takeda Chemical Industries Ltd 2-alkanoyloxypropane derivatives, their production and use
JPS6294A (en) * 1986-05-09 1987-01-06 Toyama Chem Co Ltd Novel glycerophosphoric acid derivative and salt and production thereof
JP2561478B2 (en) * 1986-07-22 1996-12-11 武田薬品工業株式会社 Glycerin derivative
US5036152A (en) * 1988-03-10 1991-07-30 Hoechst-Roussel Pharmaceuticals Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
US4888328A (en) * 1988-03-10 1989-12-19 Hoeschst-Roussel Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
DE3906952A1 (en) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3- (C (DOWN ARROW)) (DOWN ARROW) (DOWN ARROW) 6 (DOWN ARROW) -C (DOWN ARROW) 1 (DOWN ARROW) (DOWN ARROW) 8 (DOWN ARROW)) ALKANSULFINYL AND 2 SULPHONE -METHOXYMETHYL-PROPYL) - (2-TRIMETHYLAMMONIO-ETHYL) PHOSPHATES, METHOD FOR PRODUCING THE MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3918082A1 (en) * 1989-06-02 1991-01-24 Max Planck Gesellschaft AGENT FOR AUTOIMMUNE DISEASES
DE3935580C2 (en) * 1989-10-25 1998-05-28 Medmark Pharma Gmbh Use of an active pharmaceutical ingredient for the treatment of HIV infections
EP0581793A1 (en) * 1991-04-25 1994-02-09 University Of British Columbia Phosphonates and phosphinates as anti-cancer, -inflammatory, -allergy and -myocarditis agents
ES2034885B1 (en) * 1991-07-10 1994-03-01 Menarini Lab PROCEDURE FOR THE PREPARATION OF CETOALQUILGLICEROFOSFOLIPIDOS.
KR100381449B1 (en) * 1994-10-14 2003-07-18 더 리포좀 컴퍼니, 인코퍼레이티드 Application of ether lipid liposomal enzymes to pharmaceuticals
USRE39042E1 (en) * 1996-02-16 2006-03-28 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
US6007839A (en) * 1996-02-16 1999-12-28 The Liposome Company, Inc. Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5965159A (en) 1996-02-16 1999-10-12 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US6135426A (en) * 1998-01-07 2000-10-24 Briggs And Stratton Corporation Priming system for internal combustion engines
EP2091520B1 (en) 2006-11-10 2012-02-22 Alphaptose Gmbh Oral dosage form comprising tri-substituted glycerol compounds
CN101606061B (en) * 2006-11-10 2014-01-22 阿尔法普托斯有限公司 Methods and compositions for detecting receptor ligand mimetics
US8637688B2 (en) * 2006-12-20 2014-01-28 Julia Diederichs Topical dosage form comprising tri-substituted glycerol compounds
US20100136029A1 (en) * 2006-12-20 2010-06-03 Universitatsklinikum Hamburg-Eppendorf Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies
WO2013156630A1 (en) 2012-04-20 2013-10-24 Alphaptose Gmbh S-enantiomer of a tri-substituted glycerol compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009342C3 (en) * 1970-02-27 1980-12-18 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Use of glycerol alkyl ether (l) phosphoric acid (3) monocholine esters
DE2009343C3 (en) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Use of lysolecithins as immunological adjuvants
DE2009341C3 (en) * 1970-02-27 1979-06-21 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen 3-Octadecyloxy-propanol- (l) -phosphoric acid monocholine ester and process for its preparation
DE2033361C3 (en) * 1970-07-06 1980-02-21 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Acylpropanediol- (13) -phosphoric acid choline ester and process for their preparation

Also Published As

Publication number Publication date
LU77248A1 (en) 1977-12-13
CA1094455A (en) 1981-01-27
SE7705071L (en) 1977-11-05
ZA772649B (en) 1978-04-26
JPS52134027A (en) 1977-11-09
DE2619686A1 (en) 1977-11-24
NZ183981A (en) 1980-04-28
IL51988A0 (en) 1977-07-31
DE2619686C2 (en) 1986-08-07
IE44927L (en) 1977-11-04
IE44927B1 (en) 1982-05-19
JPS6146455B2 (en) 1986-10-14
IT1071329B (en) 1985-04-02
NL7704723A (en) 1977-11-08
FR2364656A1 (en) 1978-04-14
NL189672B (en) 1993-01-18
NL189672C (en) 1993-06-16
AU517586B2 (en) 1981-08-13
FR2364656B1 (en) 1980-03-07
AU2481977A (en) 1978-11-09
GB1583661A (en) 1981-01-28
BE854270A (en) 1977-11-04

Similar Documents

Publication Publication Date Title
IL51988A (en) Anti-tumor agents containing lysolecithin analogues
JPS52105316A (en) Bubble generators
GB2016007B (en) W-halo-pgi2 analogues
IL51989A0 (en) Tumor antigens comprising lysolecithin analogs
ZA771317B (en) Antitumor agents
JPS5377489A (en) Static holder
HK7482A (en) Prostaglandin analogues
IL52668A0 (en) Cephalosporin analogues
AU510216B2 (en) 13-thiaprestaglandin analogues
JPS52149283A (en) Activating agents containing phosphor for perrcompounds
JPS5357083A (en) Bubble detector
JPS532670A (en) Carpet
JPS5331693A (en) Antiibacterial agents
ZA776821B (en) Antirhinovirus agents
JPS52101064A (en) Reference surface detector
GB1556365A (en) Antiviral agents
ZA776789B (en) Antirhinovirus agents
JPS52155274A (en) Blisterless carpet
JPS5332530A (en) Carpet
JPS51145571A (en) Foaming substrate
JPS52130723A (en) Chalk
ZA771462B (en) Prostagladin analogues
GB2015535B (en) -endorphin analogues
ZA762548B (en) New prostaglandin analogues
JPS52105755A (en) Stabilizing oxcillator